| Previous Section | Index | Home Page |
Hospital Beds
Mr. Battle: To ask the Secretary of State for Health how many public and private beds there (a) were in 1985, (b) were in 1990 and (c) are currently in the Leeds general infirmary, St. James hospital and in the Leeds Healthcare region as a whole. [18343]
Mr. Horam: The information available centrally is shown in the tables. Organisational changes that have taken place over the 10-year period mean that data are not directly comparable.
| United Leeds Teaching Hospitals NHS Trust | St. James's University Hospital NHS Trust | Leeds District Health Authority | |
|---|---|---|---|
| 1985 | 1,232 | 1,379 | 5,717 |
| 1990-91 | 1,223 | 1,369 | 4,478 |
| 1994-95 | 1,492 | 1,117 | 4,078 |
Source: DH SH3 returns (1985); KHO3 returns (1990-91 and 1994-95).
| United Leeds Teaching Hospitals NHS Trust | St. James's University Hospital NHS Trust | Leeds District Health Authority | |
|---|---|---|---|
| 1985 | 11 | 0 | 16 |
| 1990-91 | n/a | n/a | 4 |
| 1994-95 | n/a | n/a | n/a |
Source: DH SH3 returns (1985): KHO2 returns (1990-91).
Information on numbers of amenity beds ceased to be collected centrally from 1 April 1991 when the power of authorisation for private beds was delegated to health authorities and trusts.
5 Mar 1996 : Column: 186
Mr. Pearson:
To ask the Secretary of State for Health how many patients are registered by the family health services authorities in England and Wales. [18367]
Mr. Malone:
The available data are contained in the general medical services statistics for England and Wales (April 1995), copies of which are available in the Library.
Dr. Lynne Jones:
To ask the Secretary of State for Health what is his policy on the collection of legal costs he is awarded by the courts following an individual's litigation against him and his Department. [18478]
Mr. Horam:
The Department of Health has no specific policy on enforcement of costs orders. Each case is decided on the basis of the costs incurred and the difficulty and cost of enforcement. Where a case is struck out at an early stage, the costs involved are minimum and although an order for costs may be sought, the costs of enforcement are rarely justified.
Mr. Redmond:
To ask the Secretary of State for Health on what occasions the chief medical officer has discussed the control of MRSA with Houghs Healthcare. [18826]
Mr. Horam:
The chief medical officer has had no discussions with Houghs Healthcare. He is aware of the leaflet about MRSA which Houghs Healthcare has sent to all Members of Parliament and considers it inaccurate.
Mr. Redmond:
To ask the Secretary of State for Health if he will ascertain and publish the reasons for the resignation of Ms Vanessa White, the chief executive of Dorset community trust, and the amount of severance payments made to her. [18827]
Mr. Malone:
This is a matter for the trust.
Mr. Barron:
To ask the Secretary of State for Health how many of the medicines listed in the Prodigy project are (a) generic and (b) brand-named; and how this balance was reached. [18736]
Mr. Malone:
I refer the hon. Member to the reply I gave my hon. Friend the Member for Croydon, North-East (Mr. Congdon) on 19 December 1995, columns 1154-55.
Mr. Barron:
To ask the Secretary of State for Health what is his policy on the establishment of a national formulary for prescribing, and if he intends the Prodigy project to be a pilot for a formulary. [18727]
Mr. Malone:
There are no plans to establish a national prescribing formulary. General practitioners including those using the Prodigy system, are free to prescribe the drugs of their choice.
Mr. Barron:
To ask the Secretary of State for Health what is the aim of the Prodigy project. [18734]
5 Mar 1996 : Column: 187
Mr. Malone:
I refer the hon. Member to the reply I gave my hon. Friend the Member for Macclesfield (Mr. Winterton) on 18 December 1995, columns 946.
Mr. Barron:
To ask the Secretary of State for Health if he will list how the money allocated by his Department to the Prodigy project is being spent; and what sums are being contributed by the participating IT software companies. [18770]
Mr. Malone:
I refer the hon. Member to the reply I gave my hon. Friend the Member for Macclesfield on 18 December 1995, column 946. Information relating to expenditure by the participating information technology software companies is commercially confidential.
Mr. Barron:
To ask the Secretary of State for Health if he will list the IT software companies participating in the Prodigy project. [18733]
Mr. Malone:
AAH Meditel; EMIS; Genisyst; Medical Care Systems (in conjunction with Digitalis of the Netherlands) and VAMP.
Mr. Barron:
To ask the Secretary of State for Health if he will list (a) the numbers and types of general practices participating in the Prodigy project, (b) their locations by region or district and (c) their fundholding status; and if he will make a statement on how the practices were chosen. [18769]
Mr. Malone:
I refer the hon. Member to the reply I gave my hon. Friend the Member for Macclesfield on 18 December 1995, column 945.
Mr. Barron:
To ask the Secretary of State for Health what representations, and from whom, he has so far received on the Prodigy project. [18735]
Mr. Malone:
Representations have been made by a number of bodies including patient organisations, pharmaceutical companies and the Association of the British Pharmaceutical Industry. In addition, views have been expressed by professional medical bodies, including the General Medical Services Council and the Royal College of General Practitioners as part of the consultation process.
Mr. Soley:
To ask the Secretary of State for Health how many live births were registered in England and Wales during 1995. [18860]
Mr. Horam:
The provisional count of the number of live births registered in England and Wales during 1995 is 646,511.
Mr. Redmond:
To ask the Secretary of State for Health how many patients were waiting for in-patient treatment at the end of each of the last five years. [18828]
Mr. Horam:
The information available is contained in "Hospital Waiting List Statistics: England at 31 March 1991-95", copies of which are available in the Library.
5 Mar 1996 : Column: 188
Mr. Martyn Jones:
To ask the Secretary of State for Health what research his Department has (a) commissioned and (b) evaluated on links between lindane usage and population cancer clusters. [18728]
Mr. Horam:
The Department of Health's independent expert advisory Committee on the Carcinogenicity of Chemicals in Food, Consumer Products and the Environment reviewed the available epidemiological data on breast cancer in women and levels of lindane in serum and breast fat tissue at its meeting on the 16 March 1995. The committee concluded that there was no clear evidence of an association between serum and levels of lindane in fat and breast cancer at the present time, and recommended that the matter be kept under review. No research has been specifically commissioned by the Department.
Mr. Rathbone:
To ask the Secretary of State for Health when he last assessed plans for neurological services in Sussex; and if he will make a statement. [18660]
Mr. Horam:
The provision of neurological services in Sussex is a matter for the health authorities concerned, which are currently considering options for the development of neurosciences and neurosurgery services. Their decision may require to be referred to my right hon. Friend the Secretary of State for Health.
Mr. Denham:
To ask the Secretary of State for Health what assumptions he has made in his calculation of the cost to local authorities of implementing the changes to capital asset levels for long-term care of (a) the cost of local authority residential care (i) in London and (ii) outside London, (b) the cost of private and voluntary residential care (i) in London and (ii) outside London, (c) the cost of nursing home care (i) in London and (ii) outside London, (d) the average client contribution to each type of residential care, (e) the number of current residents who will be affected by the proposed changes in capital asset levels, (f) the number of self-funders who will now become eligible for assistance in (i) nursing homes and (ii) residential homes and the consequent additional costs to local authorities and (g) the number of new entrants to residential care who will receive local authority support in 1996-97. [18963]
Mr. Bowis:
A range of factors and assumptions was used in calculating this cost, including consideration of a survey conducted by the local authority associations.
| Next Section | Index | Home Page |